This pipeline computes the correlation between significant arm-level copy number variations (cnvs) and selected clinical features.
Testing the association between copy number variation 81 arm-level events and 8 clinical features across 512 patients, 157 significant findings detected with Q value < 0.25.
-
1p gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
-
1q gain cnv correlated to 'YEARS_TO_BIRTH'.
-
3p gain cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.
-
3q gain cnv correlated to 'Time to Death' and 'YEARS_TO_BIRTH'.
-
4q gain cnv correlated to 'YEARS_TO_BIRTH'.
-
5p gain cnv correlated to 'Time to Death' and 'YEARS_TO_BIRTH'.
-
5q gain cnv correlated to 'Time to Death' and 'RACE'.
-
7p gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'KARNOFSKY_PERFORMANCE_SCORE', and 'RACE'.
-
7q gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
8q gain cnv correlated to 'RADIATION_THERAPY'.
-
9p gain cnv correlated to 'GENDER' and 'RADIATION_THERAPY'.
-
9q gain cnv correlated to 'GENDER', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
-
10p gain cnv correlated to 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
-
10q gain cnv correlated to 'HISTOLOGICAL_TYPE'.
-
11p gain cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
-
12p gain cnv correlated to 'RADIATION_THERAPY'.
-
12q gain cnv correlated to 'Time to Death'.
-
13q gain cnv correlated to 'RADIATION_THERAPY'.
-
15q gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'KARNOFSKY_PERFORMANCE_SCORE'.
-
16p gain cnv correlated to 'YEARS_TO_BIRTH'.
-
16q gain cnv correlated to 'HISTOLOGICAL_TYPE'.
-
17p gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
-
17q gain cnv correlated to 'Time to Death'.
-
18p gain cnv correlated to 'Time to Death'.
-
18q gain cnv correlated to 'Time to Death'.
-
19p gain cnv correlated to 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
-
19q gain cnv correlated to 'Time to Death' and 'YEARS_TO_BIRTH'.
-
20p gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'KARNOFSKY_PERFORMANCE_SCORE'.
-
20q gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'KARNOFSKY_PERFORMANCE_SCORE'.
-
21q gain cnv correlated to 'YEARS_TO_BIRTH'.
-
22q gain cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
-
xp gain cnv correlated to 'HISTOLOGICAL_TYPE'.
-
xq gain cnv correlated to 'YEARS_TO_BIRTH', 'GENDER', 'HISTOLOGICAL_TYPE', and 'ETHNICITY'.
-
1p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
-
1q loss cnv correlated to 'HISTOLOGICAL_TYPE'.
-
2p loss cnv correlated to 'RADIATION_THERAPY'.
-
2q loss cnv correlated to 'HISTOLOGICAL_TYPE'.
-
3p loss cnv correlated to 'Time to Death' and 'KARNOFSKY_PERFORMANCE_SCORE'.
-
3q loss cnv correlated to 'Time to Death'.
-
4p loss cnv correlated to 'YEARS_TO_BIRTH', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
4q loss cnv correlated to 'HISTOLOGICAL_TYPE'.
-
5p loss cnv correlated to 'RADIATION_THERAPY' and 'HISTOLOGICAL_TYPE'.
-
5q loss cnv correlated to 'RADIATION_THERAPY' and 'HISTOLOGICAL_TYPE'.
-
6p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'RADIATION_THERAPY'.
-
6q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
8p loss cnv correlated to 'Time to Death'.
-
8q loss cnv correlated to 'Time to Death'.
-
9p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
9q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'KARNOFSKY_PERFORMANCE_SCORE'.
-
10p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
10q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
11p loss cnv correlated to 'Time to Death', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
-
11q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.
-
12q loss cnv correlated to 'HISTOLOGICAL_TYPE'.
-
13q loss cnv correlated to 'RADIATION_THERAPY'.
-
14q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'KARNOFSKY_PERFORMANCE_SCORE'.
-
16p loss cnv correlated to 'Time to Death' and 'YEARS_TO_BIRTH'.
-
16q loss cnv correlated to 'YEARS_TO_BIRTH' and 'RADIATION_THERAPY'.
-
17p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'KARNOFSKY_PERFORMANCE_SCORE', and 'ETHNICITY'.
-
18p loss cnv correlated to 'YEARS_TO_BIRTH'.
-
18q loss cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
-
19p loss cnv correlated to 'RACE' and 'ETHNICITY'.
-
19q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
-
20p loss cnv correlated to 'RADIATION_THERAPY'.
-
21q loss cnv correlated to 'KARNOFSKY_PERFORMANCE_SCORE' and 'HISTOLOGICAL_TYPE'.
-
22q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'KARNOFSKY_PERFORMANCE_SCORE'.
-
xq loss cnv correlated to 'Time to Death'.
Clinical Features |
Time to Death |
YEARS TO BIRTH |
GENDER |
RADIATION THERAPY |
KARNOFSKY PERFORMANCE SCORE |
HISTOLOGICAL TYPE |
RACE | ETHNICITY | ||
nCNV (%) | nWild-Type | logrank test | Wilcoxon-test | Fisher's exact test | Fisher's exact test | Wilcoxon-test | Fisher's exact test | Fisher's exact test | Fisher's exact test | |
7q gain | 150 (29%) | 362 |
2.81e-07 (1.21e-05) |
1.96e-10 (1.82e-08) |
0.435 (0.775) |
0.00116 (0.0153) |
0.00576 (0.0541) |
0.0514 (0.228) |
0.00939 (0.0761) |
0.557 (0.849) |
6q loss | 62 (12%) | 450 |
7.35e-05 (0.0017) |
0.0291 (0.161) |
0.414 (0.755) |
0.0253 (0.15) |
0.00121 (0.0157) |
0.00115 (0.0153) |
0.0504 (0.225) |
0.563 (0.849) |
10p loss | 83 (16%) | 429 |
0 (0) |
5.96e-20 (1.29e-17) |
0.81 (0.973) |
9.18e-05 (0.00205) |
0.000203 (0.00387) |
0.00011 (0.0022) |
0.00867 (0.0723) |
0.804 (0.973) |
10q loss | 97 (19%) | 415 |
0 (0) |
2.9e-17 (4.69e-15) |
0.734 (0.942) |
2.96e-06 (0.000107) |
0.000212 (0.0039) |
3e-05 (0.000778) |
0.0278 (0.159) |
0.485 (0.813) |
7p gain | 120 (23%) | 392 |
9.05e-08 (4.89e-06) |
1.63e-10 (1.76e-08) |
0.174 (0.457) |
0.000773 (0.0111) |
0.000962 (0.0133) |
0.239 (0.553) |
0.0159 (0.106) |
0.834 (0.986) |
9p loss | 117 (23%) | 395 |
1.11e-06 (4.48e-05) |
0.00204 (0.0245) |
1 (1.00) |
0.000609 (0.00918) |
0.00199 (0.0243) |
0.0589 (0.247) |
0.605 (0.875) |
0.669 (0.896) |
1p gain | 13 (3%) | 499 |
0.016 (0.106) |
0.0126 (0.0946) |
0.263 (0.578) |
0.0344 (0.175) |
0.799 (0.973) |
0.00907 (0.0744) |
0.556 (0.849) |
1 (1.00) |
20p gain | 45 (9%) | 467 |
2.94e-12 (3.8e-10) |
7.25e-09 (5.22e-07) |
0.757 (0.957) |
0.0282 (0.159) |
0.00967 (0.0764) |
0.186 (0.473) |
0.47 (0.804) |
0.343 (0.668) |
20q gain | 44 (9%) | 468 |
2.04e-09 (1.65e-07) |
2.04e-08 (1.2e-06) |
0.341 (0.668) |
0.0282 (0.159) |
0.0145 (0.102) |
0.234 (0.549) |
0.64 (0.885) |
0.507 (0.819) |
xq gain | 41 (8%) | 471 |
0.159 (0.433) |
0.0539 (0.236) |
0.0136 (0.1) |
0.229 (0.549) |
0.519 (0.831) |
0.00437 (0.0442) |
0.611 (0.875) |
0.0254 (0.15) |
1p loss | 184 (36%) | 328 |
0.000112 (0.0022) |
0.000914 (0.0129) |
0.853 (1.00) |
1.83e-07 (8.9e-06) |
0.293 (0.615) |
1e-05 (0.000282) |
0.315 (0.636) |
0.704 (0.924) |
9q loss | 50 (10%) | 462 |
0.0035 (0.0372) |
0.00595 (0.0551) |
1 (1.00) |
0.011 (0.084) |
0.000364 (0.0059) |
0.877 (1.00) |
0.136 (0.403) |
1 (1.00) |
17p loss | 14 (3%) | 498 |
0.0587 (0.247) |
0.0397 (0.196) |
0.174 (0.457) |
1 (1.00) |
0.0168 (0.109) |
0.551 (0.849) |
1 (1.00) |
0.0599 (0.247) |
19q loss | 209 (41%) | 303 |
0.0024 (0.0273) |
0.0437 (0.207) |
0.928 (1.00) |
4.3e-06 (0.000147) |
0.353 (0.681) |
1e-05 (0.000282) |
0.918 (1.00) |
0.0929 (0.328) |
22q loss | 57 (11%) | 455 |
1.94e-08 (1.2e-06) |
2.06e-06 (7.84e-05) |
0.482 (0.813) |
0.0483 (0.22) |
0.00505 (0.0496) |
0.121 (0.375) |
0.173 (0.457) |
0.56 (0.849) |
9q gain | 24 (5%) | 488 |
0.373 (0.713) |
0.0775 (0.299) |
0.00268 (0.03) |
0.00177 (0.0225) |
0.557 (0.849) |
0.0586 (0.247) |
0.212 (0.521) |
0.661 (0.892) |
10p gain | 57 (11%) | 455 |
0.536 (0.848) |
0.0215 (0.131) |
0.258 (0.576) |
0.0159 (0.106) |
0.217 (0.53) |
0.00026 (0.00443) |
1 (1.00) |
0.136 (0.403) |
15q gain | 11 (2%) | 501 |
0.0166 (0.109) |
0.0259 (0.15) |
1 (1.00) |
0.543 (0.848) |
0.0135 (0.1) |
0.406 (0.748) |
0.496 (0.815) |
1 (1.00) |
17p gain | 20 (4%) | 492 |
0.0143 (0.102) |
0.0176 (0.112) |
0.106 (0.355) |
0.49 (0.813) |
0.678 (0.901) |
0.059 (0.247) |
0.223 (0.54) |
1 (1.00) |
19p gain | 99 (19%) | 413 |
0.629 (0.885) |
0.00964 (0.0764) |
0.262 (0.578) |
0.043 (0.206) |
0.464 (0.802) |
1e-05 (0.000282) |
0.5 (0.816) |
0.108 (0.36) |
4p loss | 72 (14%) | 440 |
0.74 (0.945) |
0.0188 (0.118) |
0.0413 (0.201) |
1 (1.00) |
0.956 (1.00) |
0.00049 (0.00774) |
0.562 (0.849) |
0.798 (0.973) |
6p loss | 30 (6%) | 482 |
0.000108 (0.0022) |
0.0548 (0.237) |
0.573 (0.853) |
0.0583 (0.247) |
0.0745 (0.289) |
0.233 (0.549) |
0.0616 (0.252) |
1 (1.00) |
11p loss | 63 (12%) | 449 |
0.0307 (0.166) |
0.265 (0.58) |
0.343 (0.668) |
0.00629 (0.0574) |
0.168 (0.45) |
0.00063 (0.00928) |
0.562 (0.849) |
0.784 (0.972) |
14q loss | 81 (16%) | 431 |
2.47e-05 (0.000666) |
3.84e-05 (0.000958) |
1 (1.00) |
0.194 (0.481) |
0.035 (0.177) |
0.2 (0.495) |
0.218 (0.53) |
0.452 (0.795) |
3p gain | 11 (2%) | 501 |
0.039 (0.194) |
0.0849 (0.311) |
0.551 (0.849) |
1 (1.00) |
0.805 (0.973) |
0.0288 (0.161) |
1 (1.00) |
1 (1.00) |
3q gain | 8 (2%) | 504 |
0.0022 (0.0259) |
0.0332 (0.172) |
0.476 (0.81) |
0.414 (0.755) |
0.302 (0.621) |
0.0914 (0.325) |
1 (1.00) |
1 (1.00) |
5p gain | 11 (2%) | 501 |
0.0305 (0.166) |
0.0321 (0.17) |
1 (1.00) |
0.543 (0.848) |
0.791 (0.973) |
0.243 (0.555) |
0.079 (0.301) |
1 (1.00) |
5q gain | 9 (2%) | 503 |
0.042 (0.203) |
0.0627 (0.256) |
0.521 (0.831) |
1 (1.00) |
0.97 (1.00) |
0.584 (0.857) |
0.0548 (0.237) |
1 (1.00) |
9p gain | 17 (3%) | 495 |
0.58 (0.857) |
0.104 (0.35) |
0.0442 (0.207) |
0.0353 (0.177) |
0.574 (0.853) |
0.236 (0.549) |
0.653 (0.891) |
1 (1.00) |
11p gain | 30 (6%) | 482 |
0.179 (0.459) |
0.0295 (0.162) |
0.348 (0.672) |
0.181 (0.464) |
0.639 (0.885) |
0.0081 (0.07) |
1 (1.00) |
0.431 (0.77) |
19q gain | 25 (5%) | 487 |
1.92e-07 (8.9e-06) |
7.02e-06 (0.000228) |
0.416 (0.755) |
0.069 (0.274) |
0.0675 (0.271) |
0.155 (0.429) |
0.0983 (0.337) |
0.67 (0.896) |
22q gain | 23 (4%) | 489 |
0.645 (0.888) |
0.0457 (0.213) |
0.831 (0.985) |
0.121 (0.375) |
0.19 (0.478) |
0.00383 (0.04) |
0.731 (0.94) |
0.159 (0.433) |
3p loss | 30 (6%) | 482 |
0.0496 (0.223) |
0.883 (1.00) |
0.45 (0.795) |
0.243 (0.555) |
0.00192 (0.024) |
0.915 (1.00) |
0.312 (0.633) |
0.431 (0.77) |
5p loss | 35 (7%) | 477 |
0.871 (1.00) |
0.254 (0.571) |
0.862 (1.00) |
0.00747 (0.0658) |
0.357 (0.686) |
0.00983 (0.0767) |
0.57 (0.853) |
0.153 (0.427) |
5q loss | 32 (6%) | 480 |
0.28 (0.595) |
0.29 (0.611) |
0.583 (0.857) |
0.00504 (0.0496) |
0.67 (0.896) |
0.04 (0.196) |
0.662 (0.892) |
0.712 (0.924) |
11q loss | 21 (4%) | 491 |
9.86e-05 (0.00213) |
0.149 (0.418) |
1 (1.00) |
0.081 (0.304) |
0.0821 (0.304) |
0.0141 (0.102) |
1 (1.00) |
1 (1.00) |
16p loss | 14 (3%) | 498 |
0.052 (0.229) |
0.000244 (0.00427) |
1 (1.00) |
0.266 (0.581) |
0.149 (0.418) |
0.741 (0.945) |
0.582 (0.857) |
0.239 (0.553) |
16q loss | 22 (4%) | 490 |
0.0745 (0.289) |
0.000217 (0.0039) |
0.664 (0.892) |
0.0212 (0.131) |
0.0737 (0.289) |
0.513 (0.825) |
0.491 (0.813) |
0.652 (0.891) |
18q loss | 62 (12%) | 450 |
0.573 (0.853) |
0.0236 (0.141) |
0.499 (0.816) |
0.885 (1.00) |
0.858 (1.00) |
0.0326 (0.172) |
0.104 (0.35) |
0.784 (0.972) |
19p loss | 26 (5%) | 486 |
0.909 (1.00) |
0.677 (0.901) |
0.843 (0.993) |
0.3 (0.621) |
0.0817 (0.304) |
0.934 (1.00) |
0.0219 (0.133) |
0.0594 (0.247) |
21q loss | 38 (7%) | 474 |
0.694 (0.917) |
0.495 (0.815) |
0.737 (0.944) |
0.148 (0.418) |
0.00752 (0.0658) |
0.00412 (0.0424) |
0.586 (0.857) |
1 (1.00) |
1q gain | 23 (4%) | 489 |
0.457 (0.8) |
5.1e-05 (0.00122) |
0.522 (0.831) |
0.655 (0.891) |
0.112 (0.364) |
0.0831 (0.306) |
0.276 (0.59) |
0.385 (0.722) |
4q gain | 7 (1%) | 505 |
0.11 (0.364) |
0.0109 (0.084) |
0.47 (0.804) |
0.259 (0.576) |
0.157 (0.432) |
1 (1.00) |
1 (1.00) |
|
8q gain | 55 (11%) | 457 |
0.719 (0.932) |
0.23 (0.549) |
0.774 (0.969) |
0.0159 (0.106) |
0.335 (0.661) |
0.176 (0.457) |
0.63 (0.885) |
0.369 (0.707) |
10q gain | 11 (2%) | 501 |
0.856 (1.00) |
0.24 (0.553) |
1 (1.00) |
0.543 (0.848) |
0.336 (0.661) |
0.0087 (0.0723) |
0.0933 (0.328) |
0.14 (0.409) |
12p gain | 32 (6%) | 480 |
0.301 (0.621) |
0.462 (0.8) |
0.273 (0.589) |
0.0336 (0.173) |
0.832 (0.985) |
0.471 (0.804) |
0.345 (0.669) |
0.711 (0.924) |
12q gain | 15 (3%) | 497 |
0.00551 (0.0525) |
0.324 (0.648) |
0.193 (0.481) |
0.581 (0.857) |
0.12 (0.375) |
0.8 (0.973) |
0.154 (0.427) |
0.613 (0.875) |
13q gain | 6 (1%) | 506 |
0.41 (0.753) |
0.94 (1.00) |
1 (1.00) |
0.0332 (0.172) |
0.0678 (0.271) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
16p gain | 16 (3%) | 496 |
0.616 (0.877) |
0.0319 (0.17) |
0.445 (0.787) |
0.426 (0.767) |
0.708 (0.924) |
0.146 (0.418) |
0.609 (0.875) |
0.613 (0.875) |
16q gain | 19 (4%) | 493 |
0.417 (0.755) |
0.606 (0.875) |
0.49 (0.813) |
0.461 (0.8) |
0.638 (0.885) |
0.0153 (0.106) |
0.677 (0.901) |
0.623 (0.88) |
17q gain | 23 (4%) | 489 |
0.00836 (0.0713) |
0.118 (0.374) |
0.0858 (0.312) |
0.663 (0.892) |
0.961 (1.00) |
0.27 (0.586) |
0.26 (0.577) |
0.636 (0.885) |
18p gain | 18 (4%) | 494 |
0.0174 (0.112) |
0.906 (1.00) |
0.639 (0.885) |
0.806 (0.973) |
0.383 (0.722) |
0.564 (0.849) |
0.306 (0.626) |
0.619 (0.879) |
18q gain | 13 (3%) | 499 |
0.000572 (0.00883) |
0.781 (0.972) |
1 (1.00) |
0.145 (0.418) |
0.507 (0.819) |
0.46 (0.8) |
0.192 (0.481) |
1 (1.00) |
21q gain | 23 (4%) | 489 |
0.276 (0.59) |
0.00537 (0.0519) |
0.285 (0.603) |
0.177 (0.457) |
0.0995 (0.339) |
0.829 (0.985) |
0.391 (0.724) |
0.389 (0.722) |
xp gain | 22 (4%) | 490 |
0.54 (0.848) |
0.897 (1.00) |
0.19 (0.478) |
0.177 (0.457) |
0.502 (0.817) |
0.0197 (0.123) |
0.278 (0.593) |
1 (1.00) |
1q loss | 26 (5%) | 486 |
0.42 (0.759) |
0.113 (0.364) |
1 (1.00) |
0.83 (0.985) |
0.609 (0.875) |
0.00319 (0.0345) |
0.229 (0.549) |
1 (1.00) |
2p loss | 21 (4%) | 491 |
0.307 (0.627) |
0.528 (0.837) |
0.656 (0.891) |
0.0138 (0.101) |
0.0677 (0.271) |
0.232 (0.549) |
1 (1.00) |
0.385 (0.722) |
2q loss | 18 (4%) | 494 |
0.909 (1.00) |
0.48 (0.813) |
0.81 (0.973) |
0.121 (0.375) |
0.223 (0.54) |
0.0488 (0.221) |
1 (1.00) |
0.623 (0.88) |
3q loss | 28 (5%) | 484 |
0.0258 (0.15) |
0.443 (0.787) |
0.697 (0.917) |
0.3 (0.621) |
0.0955 (0.332) |
0.97 (1.00) |
0.276 (0.59) |
0.7 (0.92) |
4q loss | 94 (18%) | 418 |
0.471 (0.804) |
0.38 (0.722) |
0.207 (0.509) |
0.809 (0.973) |
0.745 (0.948) |
0.0158 (0.106) |
0.823 (0.983) |
0.816 (0.977) |
8p loss | 17 (3%) | 495 |
0.0474 (0.218) |
0.174 (0.457) |
0.81 (0.973) |
0.0912 (0.325) |
0.327 (0.65) |
0.386 (0.722) |
0.113 (0.364) |
0.317 (0.638) |
8q loss | 11 (2%) | 501 |
0.0439 (0.207) |
0.111 (0.364) |
0.551 (0.849) |
0.163 (0.442) |
0.507 (0.819) |
0.798 (0.973) |
0.0936 (0.328) |
0.164 (0.442) |
12q loss | 52 (10%) | 460 |
0.748 (0.951) |
0.177 (0.457) |
0.77 (0.967) |
0.125 (0.382) |
0.795 (0.973) |
0.00291 (0.032) |
0.791 (0.973) |
0.233 (0.549) |
13q loss | 115 (22%) | 397 |
0.248 (0.564) |
0.721 (0.933) |
0.136 (0.403) |
0.000328 (0.00545) |
0.137 (0.403) |
0.509 (0.82) |
0.294 (0.615) |
0.388 (0.722) |
18p loss | 67 (13%) | 445 |
0.613 (0.875) |
0.00237 (0.0273) |
0.147 (0.418) |
1 (1.00) |
0.458 (0.8) |
0.184 (0.468) |
0.097 (0.335) |
0.784 (0.972) |
20p loss | 7 (1%) | 505 |
0.904 (1.00) |
0.858 (1.00) |
0.251 (0.566) |
0.0472 (0.218) |
0.43 (0.77) |
0.495 (0.815) |
0.147 (0.418) |
0.386 (0.722) |
xq loss | 70 (14%) | 442 |
0.00654 (0.0589) |
0.149 (0.418) |
0.607 (0.875) |
0.0959 (0.332) |
0.157 (0.432) |
0.707 (0.924) |
0.651 (0.891) |
1 (1.00) |
2p gain | 14 (3%) | 498 |
0.149 (0.418) |
0.0783 (0.3) |
0.787 (0.972) |
0.387 (0.722) |
0.485 (0.813) |
0.548 (0.849) |
1 (1.00) |
0.599 (0.872) |
2q gain | 13 (3%) | 499 |
0.321 (0.645) |
0.172 (0.457) |
0.577 (0.856) |
0.142 (0.414) |
0.485 (0.813) |
0.559 (0.849) |
1 (1.00) |
0.569 (0.853) |
4p gain | 12 (2%) | 500 |
0.903 (1.00) |
0.122 (0.376) |
1 (1.00) |
0.386 (0.722) |
0.695 (0.917) |
0.0813 (0.304) |
0.168 (0.45) |
1 (1.00) |
6p gain | 7 (1%) | 505 |
0.539 (0.848) |
0.123 (0.377) |
0.251 (0.566) |
0.0867 (0.314) |
0.824 (0.983) |
0.235 (0.549) |
1 (1.00) |
1 (1.00) |
8p gain | 45 (9%) | 467 |
0.62 (0.879) |
0.867 (1.00) |
0.638 (0.885) |
0.073 (0.288) |
0.127 (0.386) |
0.299 (0.621) |
0.552 (0.849) |
0.753 (0.955) |
11q gain | 58 (11%) | 454 |
0.129 (0.388) |
0.122 (0.376) |
0.263 (0.578) |
0.886 (1.00) |
0.807 (0.973) |
0.235 (0.549) |
0.901 (1.00) |
0.767 (0.966) |
14q gain | 4 (1%) | 508 |
0.333 (0.66) |
0.252 (0.567) |
1 (1.00) |
0.64 (0.885) |
0.978 (1.00) |
0.839 (0.991) |
1 (1.00) |
0.243 (0.555) |
7p loss | 3 (1%) | 509 |
0.73 (0.94) |
0.643 (0.887) |
0.588 (0.858) |
0.526 (0.835) |
0.787 (0.972) |
1 (1.00) |
1 (1.00) |
|
7q loss | 4 (1%) | 508 |
0.884 (1.00) |
0.889 (1.00) |
0.633 (0.885) |
0.289 (0.61) |
0.49 (0.813) |
0.456 (0.8) |
1 (1.00) |
1 (1.00) |
12p loss | 28 (5%) | 484 |
0.855 (1.00) |
0.111 (0.364) |
0.563 (0.849) |
0.417 (0.755) |
0.486 (0.813) |
0.136 (0.403) |
1 (1.00) |
1 (1.00) |
15q loss | 51 (10%) | 461 |
0.313 (0.633) |
0.342 (0.668) |
0.658 (0.892) |
0.269 (0.584) |
0.774 (0.969) |
0.647 (0.888) |
0.784 (0.972) |
0.759 (0.957) |
17q loss | 9 (2%) | 503 |
0.572 (0.853) |
0.081 (0.304) |
0.521 (0.831) |
1 (1.00) |
0.119 (0.375) |
0.759 (0.957) |
1 (1.00) |
0.116 (0.372) |
20q loss | 3 (1%) | 509 |
0.926 (1.00) |
0.966 (1.00) |
0.0877 (0.316) |
1 (1.00) |
0.325 (0.648) |
0.47 (0.804) |
1 (1.00) |
0.188 (0.476) |
xp loss | 98 (19%) | 414 |
0.392 (0.724) |
0.725 (0.936) |
0.498 (0.816) |
0.115 (0.369) |
0.306 (0.626) |
0.711 (0.924) |
0.688 (0.911) |
0.103 (0.349) |
P value = 0.016 (logrank test), Q value = 0.11
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
1P GAIN MUTATED | 13 | 6 | 0.2 - 51.9 (19.9) |
1P GAIN WILD-TYPE | 495 | 119 | 0.0 - 211.2 (22.4) |
P value = 0.0126 (Wilcoxon-test), Q value = 0.095
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
1P GAIN MUTATED | 13 | 52.4 (12.7) |
1P GAIN WILD-TYPE | 498 | 42.7 (13.3) |
P value = 0.0344 (Fisher's exact test), Q value = 0.18
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
1P GAIN MUTATED | 1 | 11 |
1P GAIN WILD-TYPE | 183 | 284 |
P value = 0.00907 (Fisher's exact test), Q value = 0.074
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
1P GAIN MUTATED | 10 | 0 | 3 |
1P GAIN WILD-TYPE | 184 | 129 | 186 |
P value = 5.1e-05 (Wilcoxon-test), Q value = 0.0012
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
1Q GAIN MUTATED | 23 | 54.0 (11.1) |
1Q GAIN WILD-TYPE | 488 | 42.5 (13.2) |
P value = 0.039 (logrank test), Q value = 0.19
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
3P GAIN MUTATED | 11 | 4 | 0.2 - 49.9 (17.3) |
3P GAIN WILD-TYPE | 497 | 121 | 0.0 - 211.2 (22.6) |
P value = 0.0288 (Fisher's exact test), Q value = 0.16
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
3P GAIN MUTATED | 8 | 0 | 3 |
3P GAIN WILD-TYPE | 186 | 129 | 186 |
P value = 0.0022 (logrank test), Q value = 0.026
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
3Q GAIN MUTATED | 8 | 4 | 0.2 - 47.8 (13.1) |
3Q GAIN WILD-TYPE | 500 | 121 | 0.0 - 211.2 (22.5) |
P value = 0.0332 (Wilcoxon-test), Q value = 0.17
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
3Q GAIN MUTATED | 8 | 52.8 (11.4) |
3Q GAIN WILD-TYPE | 503 | 42.8 (13.3) |
P value = 0.0109 (Wilcoxon-test), Q value = 0.084
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
4Q GAIN MUTATED | 7 | 57.0 (15.2) |
4Q GAIN WILD-TYPE | 504 | 42.8 (13.2) |
P value = 0.0305 (logrank test), Q value = 0.17
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
5P GAIN MUTATED | 11 | 6 | 2.5 - 62.2 (24.4) |
5P GAIN WILD-TYPE | 497 | 119 | 0.0 - 211.2 (22.3) |
P value = 0.0321 (Wilcoxon-test), Q value = 0.17
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
5P GAIN MUTATED | 11 | 51.5 (12.3) |
5P GAIN WILD-TYPE | 500 | 42.8 (13.3) |
P value = 0.042 (logrank test), Q value = 0.2
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
5Q GAIN MUTATED | 9 | 5 | 2.5 - 62.2 (24.4) |
5Q GAIN WILD-TYPE | 499 | 120 | 0.0 - 211.2 (22.3) |
P value = 0.0548 (Fisher's exact test), Q value = 0.24
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 1 | 8 | 21 | 472 |
5Q GAIN MUTATED | 0 | 1 | 1 | 6 |
5Q GAIN WILD-TYPE | 1 | 7 | 20 | 466 |
P value = 9.05e-08 (logrank test), Q value = 4.9e-06
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
7P GAIN MUTATED | 120 | 48 | 0.1 - 211.2 (18.9) |
7P GAIN WILD-TYPE | 388 | 77 | 0.0 - 182.3 (24.8) |
P value = 1.63e-10 (Wilcoxon-test), Q value = 1.8e-08
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
7P GAIN MUTATED | 120 | 49.8 (12.8) |
7P GAIN WILD-TYPE | 391 | 40.9 (12.8) |
P value = 0.000773 (Fisher's exact test), Q value = 0.011
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
7P GAIN MUTATED | 27 | 82 |
7P GAIN WILD-TYPE | 157 | 213 |
P value = 0.000962 (Wilcoxon-test), Q value = 0.013
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.7 (12.6) |
7P GAIN MUTATED | 74 | 81.9 (15.3) |
7P GAIN WILD-TYPE | 232 | 88.2 (11.2) |
P value = 0.0159 (Fisher's exact test), Q value = 0.11
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 1 | 8 | 21 | 472 |
7P GAIN MUTATED | 1 | 2 | 10 | 107 |
7P GAIN WILD-TYPE | 0 | 6 | 11 | 365 |
P value = 2.81e-07 (logrank test), Q value = 1.2e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
7Q GAIN MUTATED | 150 | 57 | 0.1 - 211.2 (19.2) |
7Q GAIN WILD-TYPE | 358 | 68 | 0.0 - 182.3 (24.4) |
P value = 1.96e-10 (Wilcoxon-test), Q value = 1.8e-08
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
7Q GAIN MUTATED | 150 | 48.8 (13.1) |
7Q GAIN WILD-TYPE | 361 | 40.6 (12.7) |
P value = 0.00116 (Fisher's exact test), Q value = 0.015
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
7Q GAIN MUTATED | 36 | 99 |
7Q GAIN WILD-TYPE | 148 | 196 |
P value = 0.00576 (Wilcoxon-test), Q value = 0.054
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.7 (12.6) |
7Q GAIN MUTATED | 89 | 83.1 (14.6) |
7Q GAIN WILD-TYPE | 217 | 88.1 (11.4) |
P value = 0.0514 (Fisher's exact test), Q value = 0.23
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
7Q GAIN MUTATED | 67 | 39 | 44 |
7Q GAIN WILD-TYPE | 127 | 90 | 145 |
P value = 0.00939 (Fisher's exact test), Q value = 0.076
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 1 | 8 | 21 | 472 |
7Q GAIN MUTATED | 1 | 3 | 12 | 134 |
7Q GAIN WILD-TYPE | 0 | 5 | 9 | 338 |
P value = 0.0159 (Fisher's exact test), Q value = 0.11
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
8Q GAIN MUTATED | 12 | 40 |
8Q GAIN WILD-TYPE | 172 | 255 |
P value = 0.0442 (Fisher's exact test), Q value = 0.21
nPatients | FEMALE | MALE |
---|---|---|
ALL | 228 | 284 |
9P GAIN MUTATED | 12 | 5 |
9P GAIN WILD-TYPE | 216 | 279 |
P value = 0.0353 (Fisher's exact test), Q value = 0.18
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
9P GAIN MUTATED | 2 | 14 |
9P GAIN WILD-TYPE | 182 | 281 |
P value = 0.00268 (Fisher's exact test), Q value = 0.03
nPatients | FEMALE | MALE |
---|---|---|
ALL | 228 | 284 |
9Q GAIN MUTATED | 18 | 6 |
9Q GAIN WILD-TYPE | 210 | 278 |
P value = 0.00177 (Fisher's exact test), Q value = 0.023
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
9Q GAIN MUTATED | 2 | 21 |
9Q GAIN WILD-TYPE | 182 | 274 |
P value = 0.0586 (Fisher's exact test), Q value = 0.25
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
9Q GAIN MUTATED | 14 | 6 | 4 |
9Q GAIN WILD-TYPE | 180 | 123 | 185 |
P value = 0.0215 (Wilcoxon-test), Q value = 0.13
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
10P GAIN MUTATED | 57 | 38.5 (10.9) |
10P GAIN WILD-TYPE | 454 | 43.6 (13.5) |
P value = 0.0159 (Fisher's exact test), Q value = 0.11
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
10P GAIN MUTATED | 12 | 41 |
10P GAIN WILD-TYPE | 172 | 254 |
P value = 0.00026 (Fisher's exact test), Q value = 0.0044
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
10P GAIN MUTATED | 32 | 17 | 8 |
10P GAIN WILD-TYPE | 162 | 112 | 181 |
P value = 0.0087 (Fisher's exact test), Q value = 0.072
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
10Q GAIN MUTATED | 9 | 0 | 2 |
10Q GAIN WILD-TYPE | 185 | 129 | 187 |
P value = 0.0295 (Wilcoxon-test), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
11P GAIN MUTATED | 30 | 48.8 (14.9) |
11P GAIN WILD-TYPE | 481 | 42.6 (13.2) |
P value = 0.0081 (Fisher's exact test), Q value = 0.07
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
11P GAIN MUTATED | 4 | 9 | 17 |
11P GAIN WILD-TYPE | 190 | 120 | 172 |
P value = 0.0336 (Fisher's exact test), Q value = 0.17
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
12P GAIN MUTATED | 6 | 24 |
12P GAIN WILD-TYPE | 178 | 271 |
P value = 0.00551 (logrank test), Q value = 0.053
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
12Q GAIN MUTATED | 15 | 9 | 1.2 - 84.3 (30.2) |
12Q GAIN WILD-TYPE | 493 | 116 | 0.0 - 211.2 (22.1) |
P value = 0.0332 (Fisher's exact test), Q value = 0.17
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
13Q GAIN MUTATED | 5 | 1 |
13Q GAIN WILD-TYPE | 179 | 294 |
P value = 0.0166 (logrank test), Q value = 0.11
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
15Q GAIN MUTATED | 11 | 7 | 2.4 - 117.4 (32.5) |
15Q GAIN WILD-TYPE | 497 | 118 | 0.0 - 211.2 (22.3) |
P value = 0.0259 (Wilcoxon-test), Q value = 0.15
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
15Q GAIN MUTATED | 11 | 51.8 (13.3) |
15Q GAIN WILD-TYPE | 500 | 42.8 (13.3) |
P value = 0.0135 (Wilcoxon-test), Q value = 0.1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.7 (12.6) |
15Q GAIN MUTATED | 10 | 72.0 (19.9) |
15Q GAIN WILD-TYPE | 296 | 87.2 (12.0) |
P value = 0.0319 (Wilcoxon-test), Q value = 0.17
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
16P GAIN MUTATED | 16 | 49.8 (11.8) |
16P GAIN WILD-TYPE | 495 | 42.8 (13.3) |
P value = 0.0153 (Fisher's exact test), Q value = 0.11
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
16Q GAIN MUTATED | 13 | 1 | 5 |
16Q GAIN WILD-TYPE | 181 | 128 | 184 |
P value = 0.0143 (logrank test), Q value = 0.1
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
17P GAIN MUTATED | 20 | 8 | 8.1 - 62.2 (21.6) |
17P GAIN WILD-TYPE | 488 | 117 | 0.0 - 211.2 (22.5) |
P value = 0.0176 (Wilcoxon-test), Q value = 0.11
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
17P GAIN MUTATED | 20 | 49.9 (13.4) |
17P GAIN WILD-TYPE | 491 | 42.7 (13.3) |
P value = 0.059 (Fisher's exact test), Q value = 0.25
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
17P GAIN MUTATED | 11 | 1 | 8 |
17P GAIN WILD-TYPE | 183 | 128 | 181 |
P value = 0.00836 (logrank test), Q value = 0.071
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
17Q GAIN MUTATED | 23 | 9 | 5.8 - 62.2 (21.0) |
17Q GAIN WILD-TYPE | 485 | 116 | 0.0 - 211.2 (22.4) |
P value = 0.0174 (logrank test), Q value = 0.11
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
18P GAIN MUTATED | 18 | 9 | 0.2 - 117.5 (25.0) |
18P GAIN WILD-TYPE | 490 | 116 | 0.0 - 211.2 (22.4) |
P value = 0.000572 (logrank test), Q value = 0.0088
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
18Q GAIN MUTATED | 13 | 8 | 0.2 - 51.9 (29.1) |
18Q GAIN WILD-TYPE | 495 | 117 | 0.0 - 211.2 (22.3) |
P value = 0.00964 (Wilcoxon-test), Q value = 0.076
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
19P GAIN MUTATED | 98 | 46.3 (14.2) |
19P GAIN WILD-TYPE | 413 | 42.2 (13.0) |
P value = 0.043 (Fisher's exact test), Q value = 0.21
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
19P GAIN MUTATED | 44 | 48 |
19P GAIN WILD-TYPE | 140 | 247 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00028
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
19P GAIN MUTATED | 20 | 19 | 60 |
19P GAIN WILD-TYPE | 174 | 110 | 129 |
P value = 1.92e-07 (logrank test), Q value = 8.9e-06
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
19Q GAIN MUTATED | 25 | 11 | 0.2 - 54.8 (16.8) |
19Q GAIN WILD-TYPE | 483 | 114 | 0.0 - 211.2 (23.5) |
P value = 7.02e-06 (Wilcoxon-test), Q value = 0.00023
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
19Q GAIN MUTATED | 25 | 55.2 (11.7) |
19Q GAIN WILD-TYPE | 486 | 42.4 (13.1) |
P value = 2.94e-12 (logrank test), Q value = 3.8e-10
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
20P GAIN MUTATED | 45 | 23 | 0.5 - 54.8 (17.7) |
20P GAIN WILD-TYPE | 463 | 102 | 0.0 - 211.2 (23.5) |
P value = 7.25e-09 (Wilcoxon-test), Q value = 5.2e-07
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
20P GAIN MUTATED | 45 | 54.4 (11.8) |
20P GAIN WILD-TYPE | 466 | 41.9 (13.0) |
P value = 0.0282 (Fisher's exact test), Q value = 0.16
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
20P GAIN MUTATED | 9 | 32 |
20P GAIN WILD-TYPE | 175 | 263 |
P value = 0.00967 (Wilcoxon-test), Q value = 0.076
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.7 (12.6) |
20P GAIN MUTATED | 28 | 81.4 (13.5) |
20P GAIN WILD-TYPE | 278 | 87.2 (12.4) |
P value = 2.04e-09 (logrank test), Q value = 1.6e-07
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
20Q GAIN MUTATED | 44 | 22 | 0.5 - 117.5 (17.6) |
20Q GAIN WILD-TYPE | 464 | 103 | 0.0 - 211.2 (23.5) |
P value = 2.04e-08 (Wilcoxon-test), Q value = 1.2e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
20Q GAIN MUTATED | 44 | 54.3 (12.2) |
20Q GAIN WILD-TYPE | 467 | 41.9 (13.0) |
P value = 0.0282 (Fisher's exact test), Q value = 0.16
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
20Q GAIN MUTATED | 9 | 32 |
20Q GAIN WILD-TYPE | 175 | 263 |
P value = 0.0145 (Wilcoxon-test), Q value = 0.1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.7 (12.6) |
20Q GAIN MUTATED | 27 | 81.5 (13.8) |
20Q GAIN WILD-TYPE | 279 | 87.2 (12.4) |
P value = 0.00537 (Wilcoxon-test), Q value = 0.052
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
21Q GAIN MUTATED | 23 | 52.5 (17.3) |
21Q GAIN WILD-TYPE | 488 | 42.5 (13.0) |
P value = 0.0457 (Wilcoxon-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
22Q GAIN MUTATED | 23 | 48.0 (11.3) |
22Q GAIN WILD-TYPE | 488 | 42.8 (13.4) |
P value = 0.00383 (Fisher's exact test), Q value = 0.04
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
22Q GAIN MUTATED | 3 | 4 | 16 |
22Q GAIN WILD-TYPE | 191 | 125 | 173 |
P value = 0.0197 (Fisher's exact test), Q value = 0.12
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
XP GAIN MUTATED | 14 | 5 | 3 |
XP GAIN WILD-TYPE | 180 | 124 | 186 |
P value = 0.0539 (Wilcoxon-test), Q value = 0.24
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
XQ GAIN MUTATED | 41 | 39.5 (12.1) |
XQ GAIN WILD-TYPE | 470 | 43.3 (13.4) |
P value = 0.0136 (Fisher's exact test), Q value = 0.1
nPatients | FEMALE | MALE |
---|---|---|
ALL | 228 | 284 |
XQ GAIN MUTATED | 26 | 15 |
XQ GAIN WILD-TYPE | 202 | 269 |
P value = 0.00437 (Fisher's exact test), Q value = 0.044
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
XQ GAIN MUTATED | 20 | 15 | 6 |
XQ GAIN WILD-TYPE | 174 | 114 | 183 |
P value = 0.0254 (Fisher's exact test), Q value = 0.15
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 32 | 446 |
XQ GAIN MUTATED | 6 | 30 |
XQ GAIN WILD-TYPE | 26 | 416 |
P value = 0.000112 (logrank test), Q value = 0.0022
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
1P LOSS MUTATED | 181 | 27 | 0.1 - 182.3 (23.2) |
1P LOSS WILD-TYPE | 327 | 98 | 0.0 - 211.2 (21.3) |
P value = 0.000914 (Wilcoxon-test), Q value = 0.013
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
1P LOSS MUTATED | 183 | 45.4 (12.8) |
1P LOSS WILD-TYPE | 328 | 41.6 (13.5) |
P value = 1.83e-07 (Fisher's exact test), Q value = 8.9e-06
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
1P LOSS MUTATED | 93 | 79 |
1P LOSS WILD-TYPE | 91 | 216 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00028
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
1P LOSS MUTATED | 10 | 38 | 136 |
1P LOSS WILD-TYPE | 184 | 91 | 53 |
P value = 0.00319 (Fisher's exact test), Q value = 0.034
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
1Q LOSS MUTATED | 4 | 4 | 18 |
1Q LOSS WILD-TYPE | 190 | 125 | 171 |
P value = 0.0138 (Fisher's exact test), Q value = 0.1
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
2P LOSS MUTATED | 2 | 17 |
2P LOSS WILD-TYPE | 182 | 278 |
P value = 0.0488 (Fisher's exact test), Q value = 0.22
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
2Q LOSS MUTATED | 12 | 3 | 3 |
2Q LOSS WILD-TYPE | 182 | 126 | 186 |
P value = 0.0496 (logrank test), Q value = 0.22
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
3P LOSS MUTATED | 29 | 11 | 0.1 - 84.3 (24.3) |
3P LOSS WILD-TYPE | 479 | 114 | 0.0 - 211.2 (22.3) |
P value = 0.00192 (Wilcoxon-test), Q value = 0.024
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.7 (12.6) |
3P LOSS MUTATED | 21 | 78.6 (13.9) |
3P LOSS WILD-TYPE | 285 | 87.3 (12.3) |
P value = 0.0258 (logrank test), Q value = 0.15
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
3Q LOSS MUTATED | 28 | 13 | 0.0 - 117.4 (24.2) |
3Q LOSS WILD-TYPE | 480 | 112 | 0.1 - 211.2 (22.3) |
P value = 0.0188 (Wilcoxon-test), Q value = 0.12
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
4P LOSS MUTATED | 72 | 46.3 (12.8) |
4P LOSS WILD-TYPE | 439 | 42.5 (13.4) |
P value = 0.0413 (Fisher's exact test), Q value = 0.2
nPatients | FEMALE | MALE |
---|---|---|
ALL | 228 | 284 |
4P LOSS MUTATED | 24 | 48 |
4P LOSS WILD-TYPE | 204 | 236 |
P value = 0.00049 (Fisher's exact test), Q value = 0.0077
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
4P LOSS MUTATED | 14 | 19 | 39 |
4P LOSS WILD-TYPE | 180 | 110 | 150 |
P value = 0.0158 (Fisher's exact test), Q value = 0.11
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
4Q LOSS MUTATED | 25 | 23 | 46 |
4Q LOSS WILD-TYPE | 169 | 106 | 143 |
P value = 0.00747 (Fisher's exact test), Q value = 0.066
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
5P LOSS MUTATED | 5 | 27 |
5P LOSS WILD-TYPE | 179 | 268 |
P value = 0.00983 (Fisher's exact test), Q value = 0.077
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
5P LOSS MUTATED | 19 | 11 | 5 |
5P LOSS WILD-TYPE | 175 | 118 | 184 |
P value = 0.00504 (Fisher's exact test), Q value = 0.05
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
5Q LOSS MUTATED | 4 | 25 |
5Q LOSS WILD-TYPE | 180 | 270 |
P value = 0.04 (Fisher's exact test), Q value = 0.2
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
5Q LOSS MUTATED | 19 | 6 | 7 |
5Q LOSS WILD-TYPE | 175 | 123 | 182 |
P value = 0.000108 (logrank test), Q value = 0.0022
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
6P LOSS MUTATED | 30 | 13 | 0.2 - 65.4 (19.3) |
6P LOSS WILD-TYPE | 478 | 112 | 0.0 - 211.2 (22.5) |
P value = 0.0548 (Wilcoxon-test), Q value = 0.24
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
6P LOSS MUTATED | 30 | 47.7 (14.7) |
6P LOSS WILD-TYPE | 481 | 42.7 (13.2) |
P value = 0.0583 (Fisher's exact test), Q value = 0.25
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
6P LOSS MUTATED | 5 | 20 |
6P LOSS WILD-TYPE | 179 | 275 |
P value = 7.35e-05 (logrank test), Q value = 0.0017
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
6Q LOSS MUTATED | 61 | 20 | 0.1 - 65.4 (18.0) |
6Q LOSS WILD-TYPE | 447 | 105 | 0.0 - 211.2 (23.6) |
P value = 0.0291 (Wilcoxon-test), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
6Q LOSS MUTATED | 62 | 46.4 (13.7) |
6Q LOSS WILD-TYPE | 449 | 42.5 (13.2) |
P value = 0.0253 (Fisher's exact test), Q value = 0.15
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
6Q LOSS MUTATED | 13 | 41 |
6Q LOSS WILD-TYPE | 171 | 254 |
P value = 0.00121 (Wilcoxon-test), Q value = 0.016
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.7 (12.6) |
6Q LOSS MUTATED | 40 | 81.0 (13.2) |
6Q LOSS WILD-TYPE | 266 | 87.5 (12.3) |
P value = 0.00115 (Fisher's exact test), Q value = 0.015
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
6Q LOSS MUTATED | 37 | 10 | 15 |
6Q LOSS WILD-TYPE | 157 | 119 | 174 |
P value = 0.0504 (Fisher's exact test), Q value = 0.23
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 1 | 8 | 21 | 472 |
6Q LOSS MUTATED | 1 | 1 | 5 | 55 |
6Q LOSS WILD-TYPE | 0 | 7 | 16 | 417 |
P value = 0.0474 (logrank test), Q value = 0.22
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
8P LOSS MUTATED | 16 | 6 | 0.2 - 51.9 (19.9) |
8P LOSS WILD-TYPE | 492 | 119 | 0.0 - 211.2 (22.5) |
P value = 0.0439 (logrank test), Q value = 0.21
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
8Q LOSS MUTATED | 11 | 4 | 0.2 - 51.9 (19.1) |
8Q LOSS WILD-TYPE | 497 | 121 | 0.0 - 211.2 (22.6) |
P value = 1.11e-06 (logrank test), Q value = 4.5e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
9P LOSS MUTATED | 116 | 46 | 0.1 - 169.8 (21.2) |
9P LOSS WILD-TYPE | 392 | 79 | 0.0 - 211.2 (22.5) |
P value = 0.00204 (Wilcoxon-test), Q value = 0.024
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
9P LOSS MUTATED | 116 | 46.2 (13.2) |
9P LOSS WILD-TYPE | 395 | 42.0 (13.3) |
P value = 0.000609 (Fisher's exact test), Q value = 0.0092
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
9P LOSS MUTATED | 25 | 79 |
9P LOSS WILD-TYPE | 159 | 216 |
P value = 0.00199 (Wilcoxon-test), Q value = 0.024
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.7 (12.6) |
9P LOSS MUTATED | 75 | 83.1 (13.0) |
9P LOSS WILD-TYPE | 231 | 87.8 (12.3) |
P value = 0.0589 (Fisher's exact test), Q value = 0.25
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
9P LOSS MUTATED | 55 | 23 | 39 |
9P LOSS WILD-TYPE | 139 | 106 | 150 |
P value = 0.0035 (logrank test), Q value = 0.037
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
9Q LOSS MUTATED | 50 | 21 | 0.1 - 169.8 (21.6) |
9Q LOSS WILD-TYPE | 458 | 104 | 0.0 - 211.2 (22.5) |
P value = 0.00595 (Wilcoxon-test), Q value = 0.055
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
9Q LOSS MUTATED | 50 | 48.1 (14.7) |
9Q LOSS WILD-TYPE | 461 | 42.4 (13.1) |
P value = 0.011 (Fisher's exact test), Q value = 0.084
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
9Q LOSS MUTATED | 8 | 33 |
9Q LOSS WILD-TYPE | 176 | 262 |
P value = 0.000364 (Wilcoxon-test), Q value = 0.0059
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.7 (12.6) |
9Q LOSS MUTATED | 32 | 80.0 (12.2) |
9Q LOSS WILD-TYPE | 274 | 87.4 (12.4) |
P value = 0 (logrank test), Q value = 0
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
10P LOSS MUTATED | 83 | 49 | 0.1 - 134.3 (16.2) |
10P LOSS WILD-TYPE | 425 | 76 | 0.0 - 211.2 (25.6) |
P value = 5.96e-20 (Wilcoxon-test), Q value = 1.3e-17
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
10P LOSS MUTATED | 83 | 55.6 (11.0) |
10P LOSS WILD-TYPE | 428 | 40.5 (12.4) |
P value = 9.18e-05 (Fisher's exact test), Q value = 0.0021
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
10P LOSS MUTATED | 14 | 61 |
10P LOSS WILD-TYPE | 170 | 234 |
P value = 0.000203 (Wilcoxon-test), Q value = 0.0039
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.7 (12.6) |
10P LOSS MUTATED | 52 | 80.4 (14.9) |
10P LOSS WILD-TYPE | 254 | 88.0 (11.7) |
P value = 0.00011 (Fisher's exact test), Q value = 0.0022
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
10P LOSS MUTATED | 49 | 16 | 18 |
10P LOSS WILD-TYPE | 145 | 113 | 171 |
P value = 0.00867 (Fisher's exact test), Q value = 0.072
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 1 | 8 | 21 | 472 |
10P LOSS MUTATED | 1 | 1 | 8 | 72 |
10P LOSS WILD-TYPE | 0 | 7 | 13 | 400 |
P value = 0 (logrank test), Q value = 0
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
10Q LOSS MUTATED | 97 | 55 | 0.1 - 172.8 (17.6) |
10Q LOSS WILD-TYPE | 411 | 70 | 0.0 - 211.2 (25.5) |
P value = 2.9e-17 (Wilcoxon-test), Q value = 4.7e-15
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
10Q LOSS MUTATED | 97 | 53.4 (12.3) |
10Q LOSS WILD-TYPE | 414 | 40.5 (12.4) |
P value = 2.96e-06 (Fisher's exact test), Q value = 0.00011
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
10Q LOSS MUTATED | 15 | 73 |
10Q LOSS WILD-TYPE | 169 | 222 |
P value = 0.000212 (Wilcoxon-test), Q value = 0.0039
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.7 (12.6) |
10Q LOSS MUTATED | 60 | 80.8 (14.9) |
10Q LOSS WILD-TYPE | 246 | 88.1 (11.6) |
P value = 3e-05 (Fisher's exact test), Q value = 0.00078
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
10Q LOSS MUTATED | 57 | 19 | 21 |
10Q LOSS WILD-TYPE | 137 | 110 | 168 |
P value = 0.0278 (Fisher's exact test), Q value = 0.16
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 1 | 8 | 21 | 472 |
10Q LOSS MUTATED | 1 | 1 | 8 | 86 |
10Q LOSS WILD-TYPE | 0 | 7 | 13 | 386 |
P value = 0.0307 (logrank test), Q value = 0.17
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
11P LOSS MUTATED | 63 | 24 | 0.2 - 156.2 (20.5) |
11P LOSS WILD-TYPE | 445 | 101 | 0.0 - 211.2 (22.5) |
P value = 0.00629 (Fisher's exact test), Q value = 0.057
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
11P LOSS MUTATED | 13 | 46 |
11P LOSS WILD-TYPE | 171 | 249 |
P value = 0.00063 (Fisher's exact test), Q value = 0.0093
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
11P LOSS MUTATED | 37 | 14 | 12 |
11P LOSS WILD-TYPE | 157 | 115 | 177 |
P value = 9.86e-05 (logrank test), Q value = 0.0021
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
11Q LOSS MUTATED | 21 | 9 | 0.2 - 54.8 (18.7) |
11Q LOSS WILD-TYPE | 487 | 116 | 0.0 - 211.2 (23.2) |
P value = 0.0141 (Fisher's exact test), Q value = 0.1
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
11Q LOSS MUTATED | 13 | 6 | 2 |
11Q LOSS WILD-TYPE | 181 | 123 | 187 |
P value = 0.00291 (Fisher's exact test), Q value = 0.032
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
12Q LOSS MUTATED | 29 | 14 | 9 |
12Q LOSS WILD-TYPE | 165 | 115 | 180 |
P value = 0.000328 (Fisher's exact test), Q value = 0.0054
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
13Q LOSS MUTATED | 26 | 83 |
13Q LOSS WILD-TYPE | 158 | 212 |
P value = 2.47e-05 (logrank test), Q value = 0.00067
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
14Q LOSS MUTATED | 80 | 33 | 0.1 - 130.8 (21.3) |
14Q LOSS WILD-TYPE | 428 | 92 | 0.0 - 211.2 (22.9) |
P value = 3.84e-05 (Wilcoxon-test), Q value = 0.00096
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
14Q LOSS MUTATED | 81 | 48.7 (13.2) |
14Q LOSS WILD-TYPE | 430 | 41.9 (13.1) |
P value = 0.035 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.7 (12.6) |
14Q LOSS MUTATED | 51 | 83.5 (13.1) |
14Q LOSS WILD-TYPE | 255 | 87.3 (12.4) |
P value = 0.052 (logrank test), Q value = 0.23
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
16P LOSS MUTATED | 14 | 7 | 2.4 - 78.3 (28.6) |
16P LOSS WILD-TYPE | 494 | 118 | 0.0 - 211.2 (22.2) |
P value = 0.000244 (Wilcoxon-test), Q value = 0.0043
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
16P LOSS MUTATED | 14 | 56.1 (10.7) |
16P LOSS WILD-TYPE | 497 | 42.6 (13.2) |
P value = 0.000217 (Wilcoxon-test), Q value = 0.0039
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
16Q LOSS MUTATED | 22 | 54.3 (13.8) |
16Q LOSS WILD-TYPE | 489 | 42.5 (13.1) |
P value = 0.0212 (Fisher's exact test), Q value = 0.13
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
16Q LOSS MUTATED | 3 | 18 |
16Q LOSS WILD-TYPE | 181 | 277 |
P value = 0.0587 (logrank test), Q value = 0.25
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
17P LOSS MUTATED | 14 | 3 | 0.1 - 33.3 (15.0) |
17P LOSS WILD-TYPE | 494 | 122 | 0.0 - 211.2 (23.2) |
P value = 0.0397 (Wilcoxon-test), Q value = 0.2
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
17P LOSS MUTATED | 14 | 49.9 (12.3) |
17P LOSS WILD-TYPE | 497 | 42.8 (13.3) |
P value = 0.0168 (Wilcoxon-test), Q value = 0.11
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.7 (12.6) |
17P LOSS MUTATED | 7 | 77.1 (9.5) |
17P LOSS WILD-TYPE | 299 | 86.9 (12.6) |
P value = 0.0599 (Fisher's exact test), Q value = 0.25
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 32 | 446 |
17P LOSS MUTATED | 3 | 11 |
17P LOSS WILD-TYPE | 29 | 435 |
P value = 0.00237 (Wilcoxon-test), Q value = 0.027
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
18P LOSS MUTATED | 67 | 48.1 (14.6) |
18P LOSS WILD-TYPE | 444 | 42.2 (13.0) |
P value = 0.0236 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
18Q LOSS MUTATED | 62 | 47.1 (14.7) |
18Q LOSS WILD-TYPE | 449 | 42.4 (13.1) |
P value = 0.0326 (Fisher's exact test), Q value = 0.17
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
18Q LOSS MUTATED | 20 | 10 | 32 |
18Q LOSS WILD-TYPE | 174 | 119 | 157 |
P value = 0.0219 (Fisher's exact test), Q value = 0.13
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 1 | 8 | 21 | 472 |
19P LOSS MUTATED | 0 | 1 | 4 | 20 |
19P LOSS WILD-TYPE | 1 | 7 | 17 | 452 |
P value = 0.0594 (Fisher's exact test), Q value = 0.25
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 32 | 446 |
19P LOSS MUTATED | 4 | 19 |
19P LOSS WILD-TYPE | 28 | 427 |
P value = 0.0024 (logrank test), Q value = 0.027
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
19Q LOSS MUTATED | 206 | 38 | 0.1 - 182.3 (24.7) |
19Q LOSS WILD-TYPE | 302 | 87 | 0.0 - 211.2 (20.8) |
P value = 0.0437 (Wilcoxon-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
19Q LOSS MUTATED | 208 | 44.2 (12.5) |
19Q LOSS WILD-TYPE | 303 | 42.2 (13.8) |
P value = 4.3e-06 (Fisher's exact test), Q value = 0.00015
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
19Q LOSS MUTATED | 100 | 97 |
19Q LOSS WILD-TYPE | 84 | 198 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00028
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
19Q LOSS MUTATED | 23 | 44 | 142 |
19Q LOSS WILD-TYPE | 171 | 85 | 47 |
P value = 0.0472 (Fisher's exact test), Q value = 0.22
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
20P LOSS MUTATED | 0 | 7 |
20P LOSS WILD-TYPE | 184 | 288 |
P value = 0.00752 (Wilcoxon-test), Q value = 0.066
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.7 (12.6) |
21Q LOSS MUTATED | 28 | 80.7 (13.9) |
21Q LOSS WILD-TYPE | 278 | 87.3 (12.3) |
P value = 0.00412 (Fisher's exact test), Q value = 0.042
nPatients | ASTROCYTOMA | OLIGOASTROCYTOMA | OLIGODENDROGLIOMA |
---|---|---|---|
ALL | 194 | 129 | 189 |
21Q LOSS MUTATED | 24 | 7 | 7 |
21Q LOSS WILD-TYPE | 170 | 122 | 182 |
P value = 1.94e-08 (logrank test), Q value = 1.2e-06
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
22Q LOSS MUTATED | 57 | 28 | 0.1 - 156.2 (19.5) |
22Q LOSS WILD-TYPE | 451 | 97 | 0.0 - 211.2 (23.2) |
P value = 2.06e-06 (Wilcoxon-test), Q value = 7.8e-05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 511 | 43.0 (13.3) |
22Q LOSS MUTATED | 57 | 51.5 (13.8) |
22Q LOSS WILD-TYPE | 454 | 41.9 (12.9) |
P value = 0.0483 (Fisher's exact test), Q value = 0.22
nPatients | NO | YES |
---|---|---|
ALL | 184 | 295 |
22Q LOSS MUTATED | 13 | 38 |
22Q LOSS WILD-TYPE | 171 | 257 |
P value = 0.00505 (Wilcoxon-test), Q value = 0.05
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 306 | 86.7 (12.6) |
22Q LOSS MUTATED | 35 | 80.6 (15.1) |
22Q LOSS WILD-TYPE | 271 | 87.5 (12.0) |
P value = 0.00654 (logrank test), Q value = 0.059
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 508 | 125 | 0.0 - 211.2 (22.4) |
XQ LOSS MUTATED | 69 | 23 | 0.1 - 134.3 (18.6) |
XQ LOSS WILD-TYPE | 439 | 102 | 0.0 - 211.2 (23.6) |
-
Copy number data file = broad_values_by_arm.txt from GISTIC pipeline
-
Processed Copy number data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_Correlate_Genomic_Events_Preprocess/LGG-TP/22533657/transformed.cor.cli.txt
-
Clinical data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/Append_Data/LGG-TP/22506744/LGG-TP.merged_data.txt
-
Number of patients = 512
-
Number of significantly arm-level cnvs = 81
-
Number of selected clinical features = 8
-
Exclude regions that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.